These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 29515034)

  • 1. Nrf2 prevents Notch-induced insulin resistance and tumorigenesis in mice.
    Chartoumpekis DV; Yagishita Y; Fazzari M; Palliyaguru DL; Rao UN; Zaravinos A; Khoo NK; Schopfer FJ; Weiss KR; Michalopoulos GK; Sipula I; O'Doherty RM; Kensler TW; Wakabayashi N
    JCI Insight; 2018 Mar; 3(5):. PubMed ID: 29515034
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced Nrf2 activity worsens insulin resistance, impairs lipid accumulation in adipose tissue, and increases hepatic steatosis in leptin-deficient mice.
    Xu J; Kulkarni SR; Donepudi AC; More VR; Slitt AL
    Diabetes; 2012 Dec; 61(12):3208-18. PubMed ID: 22936178
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Curcumin upregulates the Nrf2 system by repressing inflammatory signaling-mediated Keap1 expression in insulin-resistant conditions.
    Ren L; Zhan P; Wang Q; Wang C; Liu Y; Yu Z; Zhang S
    Biochem Biophys Res Commun; 2019 Jun; 514(3):691-698. PubMed ID: 31078267
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Forced Hepatic Expression of NRF2 or NQO1 Impedes Hepatocyte Lipid Accumulation in a Lipodystrophy Mouse Model.
    Wakabayashi N; Yagishita Y; Joshi T; Kensler TW
    Int J Mol Sci; 2023 Aug; 24(17):. PubMed ID: 37686150
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gene-expression signature regulated by the KEAP1-NRF2-CUL3 axis is associated with a poor prognosis in head and neck squamous cell cancer.
    Namani A; Matiur Rahaman M; Chen M; Tang X
    BMC Cancer; 2018 Jan; 18(1):46. PubMed ID: 29306329
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epigenetic repression of miR-17 contributed to di(2-ethylhexyl) phthalate-triggered insulin resistance by targeting Keap1-Nrf2/miR-200a axis in skeletal muscle.
    Wei J; Hao Q; Chen C; Li J; Han X; Lei Z; Wang T; Wang Y; You X; Chen X; Li H; Ding Y; Huang W; Hu Y; Lin S; Shen H; Lin Y
    Theranostics; 2020; 10(20):9230-9248. PubMed ID: 32802189
    [No Abstract]   [Full Text] [Related]  

  • 7. Simultaneous K-ras activation and Keap1 deletion cause atrophy of pancreatic parenchyma.
    Hamada S; Shimosegawa T; Taguchi K; Nabeshima T; Yamamoto M; Masamune A
    Am J Physiol Gastrointest Liver Physiol; 2018 Jan; 314(1):G65-G74. PubMed ID: 28971839
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Processed Meat Protein Promoted Inflammation and Hepatic Lipogenesis by Upregulating Nrf2/Keap1 Signaling Pathway in Glrx-Deficient Mice.
    Ahmad MI; Zou X; Ijaz MU; Hussain M; Liu C; Xu X; Zhou G; Li C
    J Agric Food Chem; 2019 Aug; 67(32):8794-8809. PubMed ID: 31345023
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ezetimibe, an NPC1L1 inhibitor, is a potent Nrf2 activator that protects mice from diet-induced nonalcoholic steatohepatitis.
    Lee DH; Han DH; Nam KT; Park JS; Kim SH; Lee M; Kim G; Min BS; Cha BS; Lee YS; Sung SH; Jeong H; Ji HW; Lee MJ; Lee JS; Lee HY; Chun Y; Kim J; Komatsu M; Lee YH; Bae SH
    Free Radic Biol Med; 2016 Oct; 99():520-532. PubMed ID: 27634173
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FoxO3 inactivation promotes human cholangiocarcinoma tumorigenesis and chemoresistance through Keap1-Nrf2 signaling.
    Guan L; Zhang L; Gong Z; Hou X; Xu Y; Feng X; Wang H; You H
    Hepatology; 2016 Jun; 63(6):1914-27. PubMed ID: 26857210
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cullin 3 RING E3 ligase inactivation causes NRF2-dependent NADH reductive stress, hepatic lipodystrophy, and systemic insulin resistance.
    Gu L; Du Y; Chen J; Hasan MN; Clayton YD; Matye DJ; Friedman JE; Li T
    Proc Natl Acad Sci U S A; 2024 Apr; 121(17):e2320934121. PubMed ID: 38630726
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular mechanisms for the regulation of Nrf2-mediated cell proliferation in non-small-cell lung cancers.
    Yamadori T; Ishii Y; Homma S; Morishima Y; Kurishima K; Itoh K; Yamamoto M; Minami Y; Noguchi M; Hizawa N
    Oncogene; 2012 Nov; 31(45):4768-77. PubMed ID: 22249257
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nrf2 and Notch Signaling in Lung Cancer: Near the Crossroad.
    Sparaneo A; Fabrizio FP; Muscarella LA
    Oxid Med Cell Longev; 2016; 2016():7316492. PubMed ID: 27847554
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of pterostilbene in attenuating immune mediated devastation of pancreatic beta cells via Nrf2 signaling cascade.
    Sireesh D; Ganesh MR; Dhamodharan U; Sakthivadivel M; Sivasubramanian S; Gunasekaran P; Ramkumar KM
    J Nutr Biochem; 2017 Jun; 44():11-21. PubMed ID: 28343084
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic Activation of Hepatic Nrf2 Has No Major Effect on Fatty Acid and Glucose Metabolism in Adult Mice.
    Brachs S; Winkel AF; Polack J; Tang H; Brachs M; Margerie D; Brunner B; Jahn-Hofmann K; Ruetten H; Spranger J; Schmoll D
    PLoS One; 2016; 11(11):e0166110. PubMed ID: 27814396
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-canonical NRF2 activation promotes a pro-diabetic shift in hepatic glucose metabolism.
    Liu P; Dodson M; Li H; Schmidlin CJ; Shakya A; Wei Y; Garcia JGN; Chapman E; Kiela PR; Zhang QY; White E; Ding X; Ooi A; Zhang DD
    Mol Metab; 2021 Sep; 51():101243. PubMed ID: 33933676
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nrf2 inhibition reverses resistance to GPX4 inhibitor-induced ferroptosis in head and neck cancer.
    Shin D; Kim EH; Lee J; Roh JL
    Free Radic Biol Med; 2018 Dec; 129():454-462. PubMed ID: 30339884
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of deficiency of Kelch-like ECH-associated protein 1 on skeletal organization: a mechanism for diminished nuclear factor of activated T cells cytoplasmic 1 during osteoclastogenesis.
    Sakai E; Morita M; Ohuchi M; Kido MA; Fukuma Y; Nishishita K; Okamoto K; Itoh K; Yamamoto M; Tsukuba T
    FASEB J; 2017 Sep; 31(9):4011-4022. PubMed ID: 28515152
    [TBL] [Abstract][Full Text] [Related]  

  • 19. KEAP1/NRF2 axis regulates H
    He J; Zhang X; Lian C; Wu J; Fang Y; Ye X
    Gene; 2019 Apr; 691():8-17. PubMed ID: 30594636
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epigallocatechin gallate upregulates NRF2 to prevent diabetic nephropathy via disabling KEAP1.
    Sun W; Liu X; Zhang H; Song Y; Li T; Liu X; Liu Y; Guo L; Wang F; Yang T; Guo W; Wu J; Jin H; Wu H
    Free Radic Biol Med; 2017 Jul; 108():840-857. PubMed ID: 28457936
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.